What Happened?
San Diego,, CA-based Ensysce-Biosciences Appointed Lynn Kirkpatrick as Chief Executive Officer
About the Company
Ensysce Biosciences, San Diego, CA, is a clinical stage private biopharma with prodrug platforms that address opioid use disorder. Trypsin-Activated Abuse Protection (TAAP) technology forms an opioid prodrug that can only be activated through a 2-step internal digestive process, and therefore cannot be abused by chewing, snorting or IV administration.
About the Person
Lynn Kirkpatrick is Chief Executive Officer at Ensysce Biosciences. Previously, Lynn held various senior HR leadership roles in the industry.
Info Source
News
Short Profile